Targeting Metabolism as a Therapeutic Approach for High-Risk MYCN-Driven Neuroblastoma |
University of Pennsylvania / Nicole Anderson, PhD |
Young Investigator Grants |
2016 |
Pennsylvania |
Epigenetic regulation of self-renewal pathways in hematopoietic and leukemic stem cells |
George Washington University / Alexandros Tzatsos, MD/PhD |
Young Investigator Grants |
2012 |
District of Columbia |
Elucidating Mechanisms Driving Renal Medullary Carcinomas to Deliver a Rational Approach to Cancer
Directed Therapy
|
Dana-Farber Cancer Institute / Andrew Hong, MD |
Young Investigator Grants |
2015 |
Massachusetts |
Investigating the Role of the RNA Binding Protein LIN28 in Neuroblastoma |
Boston Children’s Hospital / John Powers |
Young Investigator Grants |
2012 |
Massachusetts |
A Translational Approach to Identify Drugs with Specific Activity Against EZH2 Mutant High Risk T-ALLs and ETP ALLs that Overexpress the JDP2 bZIP Transcription Factor |
Dana-Farber Cancer Institute / Shuning He, PhD |
Young Investigator Grants |
2015 |
Massachusetts |
Genetic Dissection of Cancer Drug Resistance and Toxicity Using Haploid Human Cells |
Stanford University / Ramin Dubey, PhD |
Young Investigator Grants |
2015 |
California |
Mechanisms of regulation of the PI#K/AKT pathway downstream of NOTCH1 in T-ALL.
|
Columbia University / Teresa Palomero, PhD |
Young Investigator Grants |
2007 |
New York |
Using zebrafish to model the molecular origins of pediatric myeloid malignancies and acute myeloid leukemia |
Dana-Farber Cancer Institute / Evisa Gjini |
Young Investigator Grants |
2011 |
Massachusetts |
Regulation of Hematopoietic Stem Cell Engraftment by the Endothelial Cell Niche |
Boston Children’s Hospital / Bradley Blaser, MD, PhD |
Young Investigator Grants |
2015 |
Massachusetts |
WIP1 Modulates Responsiveness of MB to Genotoxic Stress.
|
Aflac Cancer Center and Blood Disorders Service of Children’s Healthcare of Atlanta / Robert Craig Castellino, MD |
Young Investigator Grants |
2006 |
Georgia |